|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang CH, Cheng Y, Zhang S, Fan J and Gao
Q: Changing epidemiology of hepatocellular carcinoma in Asia. Liver
Int. 42:2029–2041. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tang Y, Xu L, Ren Y, Li Y, Yuan F, Cao M,
Zhang Y, Deng M and Yao Z: Identification and validation of a
prognostic model based on three MVI-related genes in hepatocellular
carcinoma. Int J Biol Sci. 18:261–275. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu R, Wang G, Zhang C and Bai DS: A
prognostic model for hepatocellular carcinoma based on
apoptosis-related genes. World J Surg Oncol. 19(70)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Deng FW, Chen D, Wei X, Lu S, Luo X, He J,
Liu J, Meng T, Yang A and Chen H: Development and validation of a
prognostic classifier based on HIF-1 signaling for hepatocellular
carcinoma. Aging (Albany NY). 12:3431–3450. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Huang T, Yan T, Chen G and Zhang C:
Development and validation of a gene mutation-associated nomogram
for hepatocellular carcinoma patients from four countries. Front
Genet. 12(714639)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li Y, Wu J, Li E, Xiao Z, Lei J, Zhou F,
Yin X, Hu D, Mao Y, Wu L and Wenjun L: TP53 mutation detected in
circulating exosomal DNA is associated with prognosis of patients
with hepatocellular carcinoma. Cancer Biol Ther. 23:439–445.
2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhou J, Sun HC, Wang Z, Cong WM, Wang JH,
Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, et al: Guidelines for
diagnosis and treatment of primary liver cancer in China (2017
Edition). Liver Cancer. 7:235–260. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen ZY, Lusicic A, O'Brien TJ, Velakoulis
D, Adams SJK and Kwan P: Psychotic disorders induced by
antiepileptic drugs in people with epilepsy. Brain. 139:2668–2678.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yin H, Zhou W, Meng J, Zhang D, Wu Z, Wang
T, Wang J, Wang P, Shi X, Wu S, et al: Prognostic factors of
patients with spinal chondrosarcoma: A retrospective analysis of 98
consecutive patients in a single center. Ann Surg Oncol.
21:3572–3578. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Elfadaly AN, Tsilimigras DI, Hyer JM, Paro
A, Bagante F, Ratti F, Marques HP, Soubrane O, Lam V, Poultsides
GA, et al: Impact of tumor burden score on conditional survival
after curative-intent resection for hepatocellular carcinoma: A
multi-institutional analysis. World J Surg. 45:3438–3448.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mgaieth S, Kemp W, Gow P, Fink M, Lubel J,
Nicoll A, Gazzola A, Hong T, Ryan M, Knight V, et al: Impact of
viral hepatitis aetiology on survival outcomes in hepatocellular
carcinoma: A large multicentre cohort study. J Viral Hepat.
24:982–989. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kumada T, Toyoda H, Tada T, Yasuda S and
Tanaka J: Changes in background liver function in patients with
hepatocellular carcinoma over 30 years: Comparison of child-pugh
classification and albumin bilirubin grade. Liver Cancer.
9:518–528. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pham L, Kyritsi K, Zhou T, Ceci L,
Baiocchi L, Kennedy L, Chakraborty S, Glaser S, Francis H, Alpini G
and Sato K: The functional roles of immune cells in primary liver
cancer. Am J Pathol. 192:826–836. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vigano L, Conci S, Cescon M, Fava C,
Capelli P, D'Errico A, Torzilli G, Di Tommaso L, Giuliante F,
Vecchio FM, et al: Liver resection for hepatocellular carcinoma in
patients with metabolic syndrome: A multicenter matched analysis
with HCV-related HCC. J Hepatol. 63:93–101. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zheng Y, Liu Y, Zhao S, Zheng Z, Shen C,
An L and Yuan Y: Large-scale analysis reveals a novel risk score to
predict overall survival in hepatocellular carcinoma. Cancer Manag
Res. 10:6079–6096. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
de Lima LT, Broszczak D, Zhang X, Bridle
K, Crawford D and Punyadeera C: The use of minimally invasive
biomarkers for the diagnosis and prognosis of hepatocellular
carcinoma. Biochim Biophys Acta Rev Cancer.
1874(188451)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang XF, Zhang D, Bu XF, Zhang XH and Cui
L: Identification of a novel miRNA-based recurrence and prognosis
prediction biomarker for hepatocellular carcinoma. BMC
Bioinformatics. 23(479)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Harimoto N, Yoshizumi T, Inokuchi S, Itoh
S, Adachi E, Ikeda Y, Uchiyama H, Utsunomiya T, Kajiyama K, Kimura
K, et al: Prognostic significance of preoperative controlling
nutritional status (CONUT) score in patients undergoing hepatic
resection for hepatocellular carcinoma: A multi-institutional
study. Ann Surg Oncol. 25:3316–3323. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Takagi K, Yagi T, Umeda Y, Shinoura S,
Yoshida R, Nobuoka D, Kuise T, Araki H and Fujiwara T: Preoperative
controlling nutritional status (CONUT) score for assessment of
prognosis following hepatectomy for hepatocellular carcinoma. World
J Surg. 41:2353–2360. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kaibori M, Sakai K, Matsushima H, Kosaka
H, Matsui K, De Velasco MA, Sekimoto M and Nishio K: Patients with
polyclonal hepatocellular carcinoma are at a high risk of early
recurrence and have a poor recurrence-free survival period. Hepatol
Int. 16:135–147. 2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Erstad DJ and Tanabe KK: Prognostic and
therapeutic implications of microvascular invasion in
hepatocellular carcinoma. Ann Surg Oncol. 26:1474–1493.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Imamura H, Matsuyama Y, Tanaka E, Ohkubo
T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T,
Kawasaki S and Makuuchi M: Risk factors contributing to early and
late phase intrahepatic recurrence of hepatocellular carcinoma
after hepatectomy. J Hepatol. 38:200–207. 2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sonohara F, Yamada S, Tanaka N, Suenaga M,
Takami H, Hayashi M, Niwa Y, Sugimoto H, Hattori N, Kanda M, et al:
Perioperative and prognostic implication of albumin-bilirubin-TNM
score in Child-Pugh class A hepatocellular carcinoma. Ann
Gastroenterol Surg. 3:65–74. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liang BY, Gu J, Xiong M, Zhang EL, Zhang
ZY, Chen XP and Huang ZY: Tumor size may influence the prognosis of
solitary hepatocellular carcinoma patients with cirrhosis and
without macrovascular invasion after hepatectomy. Sci Rep.
11(16343)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
He HL, Wang Q, Liu L, Luo NB, Su DK and
Jin GQ: Peritumoral edema in preoperative magnetic resonance
imaging is an independent prognostic factor for hepatocellular
carcinoma. Clin Imaging. 75:143–149. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hao S, Fan P, Chen S, Tu C and Wan C:
Distinct recurrence risk factors for intrahepatic metastasis and
multicenter occurrence after surgery in patients with
hepatocellular carcinoma. J Gastrointest Surg. 21:312–320.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang T, Lu JH, Zhai J, Lin C, Yang GS,
Zhao RH, Shen F and Wu MC: High viral load is associated with poor
overall and recurrence-free survival of hepatitis B virus-related
hepatocellular carcinoma after curative resection: A prospective
cohort study. Eur J Surg Oncol. 38:683–691. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Huang G, Lai EC, Lau WY, Zhou WP, Shen F,
Pan ZY, Fu SY and Wu MC: Posthepatectomy HBV reactivation in
hepatitis B-related hepatocellular carcinoma influences
postoperative survival in patients with preoperative low HBV-DNA
levels. Ann Surg. 257:490–505. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yoo S, Kim JY, Lim YS, Han S and Choi J:
Impact of HBsAg seroclearance on late recurrence of hepatitis B
virus-related hepatocellular carcinoma after surgical resection. J
Hepatol. 77:939–946. 2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huang G, Li PP, Lau WY, Pan ZY, Zhao LH,
Wang ZG, Wang MC and Zhou WP: Antiviral therapy reduces
hepatocellular carcinoma recurrence in patients with low HBV-DNA
levels: A randomized controlled trial. Ann Surg. 268:943–954.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chong CC, Wong GL, Wong VW, Ip PC, Cheung
YS, Wong J, Lee KF, Lai PB and Chan HL: Antiviral therapy improves
post-hepatectomy survival in patients with hepatitis B
virus-related hepatocellular carcinoma: A prospective-retrospective
study. Aliment Pharmacol Ther. 41:199–208. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang HI, Tseng TC, Liu J, Lee MH, Liu CJ,
Su TH, Batrla-Utermann R, Chan HL, Kao JH and Chen CJ:
Incorporating serum level of hepatitis B surface antigen or
omitting level of hepatitis B virus DNA does not affect calculation
of risk for hepatocellular carcinoma in patients without cirrhosis.
Clin Gastroenterol Hepatol. 14:461–468, e462. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yamashita Y, Imai D, Bekki Y, Kimura K,
Matsumoto Y, Nakagawara H, Ikegami T, Yoshizumi T, Shirabe K,
Aishima S and Maehara Y: Surgical outcomes of hepatic resection for
hepatitis b virus surface antigen-negative and hepatitis C virus
antibody-negative hepatocellular carcinoma. Ann Surg Oncol.
22:2279–2285. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen JD, Liu CJ, Lee PH, Chen PJ, Lai MY,
Kao JH and Chen DS: Hepatitis B genotypes correlate with tumor
recurrence after curative resection of hepatocellular carcinoma.
Clin Gastroenterol Hepatol. 2:64–71. 2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Choi J, Jo C and Lim YS: Tenofovir versus
entecavir on recurrence of hepatitis B virus-related hepatocellular
carcinoma after surgical resection. Hepatology. 73:661–673.
2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
He L, Xia Z, Shen J, Zhang X, Peng W, Li C
and Wen T: The different effects of adefovir dipivoxil and
telbivudine on the prognosis of hepatitis b virus-related
hepatocellular carcinoma patients after curative resection.
Medicine (Baltimore). 98(e14386)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Qi W, Shen J, Dai J, Wu Y, Zhang Y, Leng
S, Gao F, Ran S, Peng W, Zhang X, et al: Comparison of nucleoside
and nucleotide analogs in the recurrence of hepatitis B
virus-related hepatocellular carcinoma after surgical resection: A
multicenter study. Cancer Med. 10:8421–8431. 2021.PubMed/NCBI View Article : Google Scholar
|
